Cubist Systematic Strategies’s Adaptimmune Therapeutics ADAP Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-675,882
Closed -$1.07M 1391
2024
Q1
$1.07M Buy
675,882
+641,275
+1,853% +$1.01M 0.01% 1114
2023
Q4
$27.4K Buy
+34,607
New +$27.4K ﹤0.01% 1910
2023
Q3
Sell
-10,049
Closed -$9.3K 1939
2023
Q2
$9.3K Sell
10,049
-2,518
-20% -$2.33K ﹤0.01% 2066
2023
Q1
$13.7K Sell
12,567
-10,061
-44% -$11K ﹤0.01% 2654
2022
Q4
$33K Buy
+22,628
New +$33K ﹤0.01% 2994
2022
Q3
Sell
-2,094
Closed -$4K 3584
2022
Q2
$4K Sell
2,094
-42,106
-95% -$80.4K ﹤0.01% 3759
2022
Q1
$91K Sell
44,200
-36,321
-45% -$74.8K ﹤0.01% 3246
2021
Q4
$302K Buy
80,521
+22,568
+39% +$84.6K ﹤0.01% 2794
2021
Q3
$300K Buy
57,953
+48,054
+485% +$249K ﹤0.01% 2352
2021
Q2
$42K Buy
9,899
+5,699
+136% +$24.2K ﹤0.01% 2805
2021
Q1
$22K Sell
4,200
-17,482
-81% -$91.6K ﹤0.01% 2771
2020
Q4
$117K Buy
+21,682
New +$117K ﹤0.01% 2379
2020
Q3
Sell
-19,744
Closed -$198K 2467
2020
Q2
$198K Buy
+19,744
New +$198K ﹤0.01% 2039
2019
Q1
Sell
-15,233
Closed -$88K 2216
2018
Q4
$88K Buy
15,233
+3,492
+30% +$20.2K ﹤0.01% 1781
2018
Q3
$159K Sell
11,741
-8,603
-42% -$117K 0.01% 1465
2018
Q2
$241K Sell
20,344
-2,271
-10% -$26.9K 0.01% 1220
2018
Q1
$254K Buy
22,615
+3,245
+17% +$36.4K 0.01% 1254
2017
Q4
$129K Sell
19,370
-2,799
-13% -$18.6K 0.01% 1646
2017
Q3
$182K Buy
+22,169
New +$182K 0.01% 1485
2017
Q2
Sell
-1,200
Closed -$7K 1647
2017
Q1
$7K Buy
+1,200
New +$7K ﹤0.01% 1572
2016
Q1
Sell
-7
Closed 1580
2015
Q4
$0 Buy
+7
New ﹤0.01% 1738